On 20 November 2018, Astellas Pharma Inc. announced the launch of the Astellas Global Health Foundation (AGHF): a new international philanthropic...
Read more
News
31 October 2018
From the Program Lead: We have entered the pivotal Phase III stage!
With the Phase II trial showing good results on safety and efficacy for the new orally dispersible praziquantel tablets, the Consortium has entered the...
Read more
News
31 October 2018
Schistosomiasis in Kenya: an interview with Dr. Maurice R. Odiere
The forthcoming Phase III clinical trial of the Pediatric Praziquantel (PZQ) Consortium Formulation program will be conducted in Kenya, in addition to the...
Read more
News
31 October 2018
The Pediatric Praziquantel Consortium played a leading role at schistosomiasis events in Brazil and Korea
Through a series of meetings and events, the Pediatric Praziquantel Consortium presented the latest achievements of the program and aligned further on next...
Read more
News
31 October 2018
The new SCI elimination strategy
The Schistosomiasis Control Initiative (SCI) has achieved a lot since its foundation in 2002. It has helped to establish programs against parasitic worm...
Read more
News
31 October 2018
Performance Materials at Merck KGaA, Darmstadt, Germany: Key Player towards the success of the Pediatric Praziquantel Program
Read more
News
25 October 2018
Consortium Pediatric Praziquantel presenting at the 67th ASTMH Annual Meeting
Latest clinical data will be presented by the Lead of the Consortium Pediatric Praziquantel program at the 67th ASTMH (American Society of Tropical Medicine...
Read more
News
03 October 2018
Publication: Extrapolation of praziquantel pharmacokinetics to a pediatric population
In September 2018, members of the Pediatric Praziquantel Consortium published a paper on the extrapolation of praziquantel pharmacokinetics to a pediatric...
Read more
News
31 August 2018
Nature reviews publication: Global overview of schistosomiasis research and control
While considerable progress has been made to control schistosomiasis, challenges remain as there is no vaccine available and the risk for drug resistance is...
Read more
Events
24 August 2018
Consortium Pediatric Praziquantel played an important role at the 15th International Symposium on Schistosomiasis in Brazil
Latest achievements presented by the Pediatric Praziquantel Consortium partners, Farmanguinhos and Merck, at the 15th International Symposium on...
Read more
Events
25 July 2018
Pediatric Praziquantel Consortium to present its development program in Brazil
Elly Kourany-Lefoll and Daniel Lacerda de Oliveira will participate as invited speakers at the 15th International Symposium on Schistosomiasis on August 1-3...
Read more
News
22 June 2018
Executive from Merck KGaA, Darmstadt, Germany re-emphasises the importance of addressing the treatment gap of preschoolers infected with schistosomiasis
Initiation of the Phase III development program by the Pediatric Praziquantel Consortium announced at the WHA Schistosomiasis luncheon in Geneva on May 22nd...
